Inflammation After Colon Cancer Surgery Tied to Worse Outcomes
Elevated levels of inflammatory biomarkers are associated with worse outcomes for patients with stage III colon cancer, a study suggests.
Diagnosis & Disease Information
Neoadjuvant Oxaliplatin-Fluoropyrimidine Chemo Improves Colon Cancer Outcomes
Benefits include histopathologic downstaging, fewer incomplete resections, and better two-year disease control.
Artificial Intelligence-Aided Colonoscopy Does Not Increase Adenoma/Polyp Detection
AIAC group had lower adenoma and polyp detection rates; lower median number of adenomas, polyps detected per colonoscopy.
Neoadjuvant Nivolumab-Ipilimumab Could Be New Standard Care in dMMR Colon Cancer
Neoadjuvant nivolumab and ipilimumab produced an “unprecedented” major pathologic response rate in the NICHE-2 study, according to the lead study author.
Risk of Second Cancer Lower With FOLFOX Than With FULFOL
Overall, adjuvant chemotherapy does not appear to increase the risk of second cancers for patients with stage III-IV colon cancer.
Dialysis Population Has Excess Cancer Mortality
Patients on dialysis die from cancer at twice the rate as those of the same age and sex in the general population, a study found.
Prostate Cancer Screenings Fell Sharply Early in COVID-19 Pandemic
The decrease in prostate cancer screening rates was the smallest among 5 cancers studied.
Celecoxib Provides No Survival Benefit for Patients With Stage III Colon Cancer
Celecoxib failed to reduce the risk of recurrence in patients with colon cancer.
Updated Screening Guidelines for 5 Cancer Types
An update on the available cancer screening guidelines, benefits/limitations, and risks for cervical, breast, prostate, colon, and lung cancers.
Universal Health Care Associated With a Lower Risk of Death in Colon Cancer
Results suggest universal health care could reduce racial disparities in survival.
- Loading...
Loading...
Next post in Gastrointestinal Cancer
Loading... 
Loading...